Genetic Variants in PDE4D and Asthma Treatment Response
Author Information
Author(s): Malgorzata Labuda, Sophie Laberge, Julie Brière, Denis Bérubé, Patrick Beaulieu, Tomi Pastinen, Maja Krajinovic
Primary Institution: CHU Sainte-Justine, Montreal, QC, Canada
Hypothesis
Do genetic variants in the PDE4D gene affect the response to short-acting bronchodilators in children with asthma?
Conclusion
The study found that specific genetic variants in the PDE4D gene are associated with the effectiveness of asthma treatment in children.
Supporting Evidence
- The study involved 133 asthmatic children to assess the impact of genetic variants on treatment response.
- Significant differences in FEV1 change were observed between different genotypes.
- Genetic variants rs1544791 and rs1504982 were significantly associated with bronchodilator response.
Takeaway
This study looked at how certain genes might affect how well asthma medicine works in kids. They found that some kids' genes made the medicine work better or worse.
Methodology
The study assessed bronchodilator responsiveness in 133 asthmatic children by measuring the change in forced expiratory volume in one second (FEV1) after administering albuterol.
Potential Biases
Potential bias due to the exclusion of patients on long-acting bronchodilators and the reliance on self-reported atopy.
Limitations
The findings may not be applicable to non-Caucasian populations due to differences in genetic variation.
Participant Demographics
Participants were Caucasian children aged 5 to 18 years with a diagnosis of asthma.
Statistical Information
P-Value
0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website